InvestorsHub Logo
Followers 5
Posts 91
Boards Moderated 0
Alias Born 09/02/2020

Re: momoney24 post# 320226

Wednesday, 01/20/2021 8:05:59 PM

Wednesday, January 20, 2021 8:05:59 PM

Post# of 423490
Per theflyonthewall.com:

January 19, 2021
09:55 EST GILD
Early notable gainers among liquid option names on January 19th
Notable gainers among liquid option names this morning include General Motors (GM) $54.32 +4.35, Gilead (GILD) $66.24 +2.90, Macerich (MAC) $14.20 +0.62, CarMax (KMX) $111.22 +4.78, and Murphy Oil (MUR) $15.26 +0.57.
07:35 EST GILD
Morgan Stanley upgrades Gilead to Overweight at start of 'pivotal pipeline year'
As previously reported, Morgan Stanley analyst Matthew Harrison upgraded Gilead to Overweight from Equal Weight with a price target of $83, up from $67. He believes success is likely in the ongoing Trodelvy Phase 3 study in third-line plus patients and thinks hormone receptor-positive metastatic breast cancer could represent "billions in additional peak sales," Harrison tells investors. He also believes the combination of Gilead's long-acting HIV capsid inhibitor, lenacapavir, with another long-acting HIV drug presents an opportunity to extend HIV cash flows "into the 2040s," or potentially another 10 years, said the analyst, who calls 2021 a "pivotal pipeline year" for Gilead.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News